Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 26 | -38 | 99 | 31 | 263 |
| Cost of Goods | 2 | 3 | 0 | 1 | 1 |
| Gross Profit | 24 | -41 | 99 | 31 | 262 |
| Operating Expenses | 6,244 | 6,409 | 2,070 | 2,067 | 1,516 |
| Operating Income | -6,219 | -6,447 | -1,971 | -2,036 | -1,253 |
| Interest Expense | 18 | -24 | 39 | 83 | 130 |
| Other Income | 62 | 533 | 47 | 6 | 137 |
| Pre-tax Income | -6,175 | -5,890 | -1,962 | -2,113 | -1,246 |
| Income Tax | -87 | 1,011 | -76 | -60 | -51 |
| Net Income Continuous | -6,088 | -6,901 | -1,886 | -2,053 | -1,195 |
| Minority Interests | -92 | 1,031 | -80 | -81 | -67 |
| Net Income | $-5,995 | $-7,932 | $-1,807 | $-1,972 | $-1,129 |
| EPS Basic Total Ops | -2.00 | -3.10 | -0.70 | -0.80 | -0.50 |
| EPS Basic Continuous Ops | -2.05 | -2.77 | -0.70 | -0.84 | -0.49 |
| EPS Diluted Total Ops | -2.00 | -3.10 | -0.70 | -0.80 | -0.50 |
| EPS Diluted Continuous Ops | -2.05 | -2.77 | -0.70 | -0.84 | -0.49 |
| EBITDA(a) | $-6,213 | $-6,444 | $-1,968 | $-2,033 | $-1,250 |